EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ibuprofen as an adjuvant to conventional antimicrobials and essential oil compounds against skin pathogens

Shivar Simbu, Ané Orchard iD, Maryna van de Venter, Sandy van Vuuren iD

Journal of Applied Microbiology · 2024

DOI: 10.1093/jambio/lxae186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2024. Verfasst von Shivar Simbu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Parktown, 2193, South Africa. Hauptthemen laut MEDLINE: Ibuprofen, Oils, Volatile, Microbial Sensitivity Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, Council for Scientific and Industrial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Antimicrobial resistance continues to be a growing concern, resulting in increased use of drug combinations. Antibiotic adjuvants are an emerging strategy that may potentiate an antibiotics efficacy. Ibuprofen’s polypharmacological properties have been investigated for their antimicrobial and host-modulating potential. This study aimed to investigate the potential of a novel multidrug combination involving ibuprofen, essential oil compounds (EOCs), and conventional antimicrobials against skin pathogens. Methods and Results The minimum inhibitory concentrations of ibuprofen, conventional antimicrobials, and EOCs were determined and then combined and tested against 14 (reference and clinical) skin pathogens. The cytotoxicity was analysed using the MTT assay, whilst the anti-inflammatory effects were evaluated using lipopolysaccharide activated RAW264.7 murine macrophages. Four pairwise (Ibuprofen and antibiotic) (ΣFIC 0.33–0.50) and three triple (Ibuprofen and antibiotic with EOC) (ΣFIC 0.44–0.47) synergistic antimicrobial interactions were identified. These combinations demonstrated cell viability of 77.59%–100%. No combination significantly reduced nitric oxide production.

Conclusion

The results from this study provide insight into the potential of a multidrug combination involving ibuprofen with conventional antimicrobials and EOCs against common skin pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IbuprofenOils, VolatileMicrobial Sensitivity TestsAnimalsMiceRAW 264.7 CellsAnti-Infective AgentsAnti-Bacterial AgentsDrug SynergismMacrophagesSkinCell Survival

Stichwörter der Autor:innen

antibioticantimicrobialcombinationscytotoxicityessential oil compoundsynergy

Substanzen

IbuprofenOils, VolatileAnti-Infective AgentsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Parktown, 2193, South Africa.
  • Department of Biochemistry and Microbiology, Nelson Mandela University, Gqeberha, 6031, South Africa.

ORCID-Profile: Ané Orchard, Sandy van Vuuren

Förderung

  • National Research Foundation
  • Council for Scientific and Industrial Research

Zitieren

APA

Simbu, S., Orchard, A., van de Venter, M., & van Vuuren, S. (2024). Ibuprofen as an adjuvant to conventional antimicrobials and essential oil compounds against skin pathogens. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae186

Vancouver

Simbu S, Orchard A, van de Venter M, van Vuuren S. Ibuprofen as an adjuvant to conventional antimicrobials and essential oil compounds against skin pathogens. Journal of Applied Microbiology. 2024. doi:10.1093/jambio/lxae186

BibTeX
@article{Simbu2024,
  author = {Simbu, Shivar and Orchard, Ané and van de Venter, Maryna and van Vuuren, Sandy},
  title = {Ibuprofen as an adjuvant to conventional antimicrobials and essential oil compounds against skin pathogens},
  journal = {Journal of Applied Microbiology},
  year = {2024},
  doi = {10.1093/jambio/lxae186}
}
Kostenlos starten →